Ann Lee - 02 Jan 2026 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Director
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
06 Jan 2026, 19:21:56 UTC
Previous filing
25 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lee Ann Director 5850 SAN FELIPE ST., SUITE 500, HOUSTON /s/ David Snyder, Attorney-in-Fact 06 Jan 2026 0001953080

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 02 Jan 2026 Common Stock, par value $0.0001 per share 10,000 $5.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.